Inovio Pharmaceuticals
INO
#8784
Rank
S$0.20 B
Marketcap
S$2.95
Share price
-3.80%
Change (1 day)
17.00%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): S-$3.73

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S-$3.72. In 2024 the company made an earnings per share (EPS) of S-$5.11 an increase over its 2023 EPS that were of S-$7.87.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$3.73-27.01%
2024S-$5.11-35.14%
2023S-$7.87-56.62%
2022S-$18.15-19.54%
2021S-$22.5535.9%
2020S-$16.60-11.57%
2019S-$18.7715.24%
2018S-$16.29-2.78%
2017S-$16.756.93%
2016S-$15.67134.88%
2015S-$6.67-29.51%
2014S-$9.46-57.34%
2013S-$22.18146.55%
2012S-$9.0020.83%
2011S-$7.44-29.41%
2010S-$10.55-48.48%
2009S-$20.4710%
2008S-$18.6111.11%
2007S-$16.75-41.3%
2006S-$28.54-66.91%
2005S-$86.24110.61%
2004S-$40.95-61.63%
2003S-$106.71186.67%
2002S-$37.22
2001N/A-100%
2000S-$29.78-63.64%
1999S-$81.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$2.22-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$13.49-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
S-$1.62-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.51-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
S$9.81-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$4.65-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
S$8.43-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA